Many people like to mock celebrities for using the various popular weight loss drugs. “Saturday Night Live” recently did a ...

CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...

CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

Prescriptions will be forwarded to another nearby location for customers. Auto service company acquires Bessemer distribution ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

CVS Health Corp.’s Aetna unit will exit the Affordable Care Act insurance market in 2026, the company said after reporting ...

CVS Health is laying off more people who report to its Aetna building in Hartford, beginning July 26, 2025. It’s the fifth ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...